Understanding Immunotherapy for Breast Cancer - Susan G. Komen®
Immunotherapy is becoming a more prominent option for people with breast cancer, especially those with certain subtypes of breast cancer.| Susan G. Komen®
The 2025 ASCO Annual Meeting highlighted several groundbreaking developments across the landscape of breast cancer research, from early detection to cutting-edge treatments. These advances offer hope to individuals diagnosed at every stage of breast cancer, from early-stage disease to metastatic breast cancer (MBC). In this episode of Breast Cancer Breakthroughs, we speak with Dawn Hershman, […] The post Breast Cancer Breakthroughs Episode 14: Highlights from ASCO 2025 appeared first on...| Susan G. Komen®
Immunotherapy is becoming a more prominent option for people with breast cancer, especially those with certain subtypes of breast cancer.| Susan G. Komen®
In this episode of Breast Cancer Breakthroughs, we speak with Komen grantees Dr. Tarah Ballinger, medical oncologist at Indiana University School of Medicine, and Dr. Pedram Razavi, medical oncologist at Memorial Sloan Kettering Cancer Center, about the biggest highlights from the 2024 ASCO Annual Meeting and what they could mean for patients.| Susan G. Komen®
